Current Edition

Benefits

How to Harness the Benefits of Inhalation When Re-formulating Biologics

The biologics market is growing rapidly and is on track to be worth $719.14 bn by 2030, up from $366.6 bn in 2021.¹ This growth …

Continue Reading →
biologics

Cutting-edge Formulation is Needed to Enable the Next Generation of Oral Biologics

An Introduction to Oral Solid Dose Traditionally, the pharmaceutical market has been dominated by oral drug delivery – whether oral solid dose (OSD) or liquid …

Continue Reading →
chain

Effective Operations for Risk Reduction and Supply Chain Resilience

There is no denying that the market for injectable drug delivery devices is growing rapidly, with forecasts predicting an increase from $39.93 billion in 2022 …

Continue Reading →
development

Navigating the Changing Oral Solid Dose Landscape

Oral solid dose (OSD) forms have accounted for the lion’s share of the pharmaceutical market for decades, thanks to their easy administration leading to patient …

Continue Reading →
cancer

PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments

New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market PHILADELPHIA – July 27, 2022 – PCI Pharma Services …

Continue Reading →
companies

Balancing The Complexity-efficiency Equation in a Fast-changing Prefilled Syringe Packaging Market

Marcelo Cruz, Director of Business Development and Marketing at Tjoapack, discusses the fast-changing pharmaceutical market landscape and explores the latest trends in prefilled syringes. He …

Continue Reading →
driven

Korea finished drug market growth driven by generics

FDF launches at CPhI Korea as country set to become regional hub The Korean pharma market is experiencing significant growth in finished drug products, according …

Continue Reading →
DACH

TraceLink Grows Market Position in DACH Region by 215%

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, …

Continue Reading →
global

Pertinax Pharma further expands into global woundcare markets with appointment of Business Developmemt Manager

Paul Williams brings established international sales expertise to the company’s commercial growth strategy Pertinax Pharma announces that Paul Williams has been appointed to the role of …

Continue Reading →
biosimilars

Japanese pharma – no longer ‘lost in translation’

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars …

Continue Reading →